Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free AYTU Stock Alerts

Aytu BioPharma (AYTU) ESG Score & Sustainability Data

Aytu BioPharma logo
$1.38 0.00 (0.00%)
(As of 12/20/2024 05:31 PM ET)
Compare

Key ESG Takeaways for Aytu BioPharma

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Aytu BioPharma. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Aytu BioPharma seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is mostly driven by its Carbinoxamine, Methylphenidate, and Amphetamine products.
  • On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in categories , , and . The negative contribution in the impact category seems to be driven mostly by its Carbinoxamine, Amphetamine, and Methylphenidate products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, Aytu BioPharma would improve its net impact ratio by 3 percentage points.

AYTU Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+39.5%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+49.2%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+23.2%
Society First
Value set that emphasizes society impacts over other impacts.
-23.4%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+59.9%
Health First
Value set that emphasizes health impacts over other impacts.
+62.9%

Aytu BioPharma ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.60
+1.60
+1.56
+1.56
+0.21
+0.21
-0.01
+0.06
+0.07
-0.22
-0.18
+0.03
+0.00
+0.00
+1.11
+1.11
-0.00
+0.00
+0.00
-1.94
-1.94
-1.01
+2.09
+3.11
-0.34
+1.48
+1.82
+0.00
+0.00
-0.02
-0.02
+0.01
-0.00
+0.41
+0.41
-1.09
-1.07
+0.02
-0.21
-0.21
+0.01
-0.14
-0.14
+0.00
-0.09
-0.09
+0.00
-0.95
-0.94
+0.01

Upright Model Version 0.4.0
ESG Data Last Updated: March 29, 2022

Ad Behind the Markets
⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
Click here for the ticker >>>

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Aytu BioPharma ESG Score - Frequently Asked Questions

How is Aytu BioPharma doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Aytu BioPharma has a net impact ratio of 39.5%, indicating an overall positive sustainability impact. Aytu BioPharma seems to create the most significant positive value in the categories of Physical diseases, Mental diseases, and Jobs. On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in the categories of Scarce human capital, GHG emissions, and Physical diseases. Learn more on the sustainability of Aytu BioPharma.


More ESG Stocks and Research Tools

Related Companies
Stock Lists
Sustainability Tools

This page (NASDAQ:AYTU) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...
Porter & Company | Sponsored
Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average A...
MyBankTracker | Sponsored
MUST SEE: The most important video in the world right now?
If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...
InvestorPlace | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...
Banyan Hill Publishing | Sponsored